DOCSLIB.ORG

WOMEN's HEALTH Maternal Fetal Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
WOMEN's HEALTH Maternal Fetal Medicine WOMEN’S HEALTH Maternal Fetal Medicine As a woman, you deserve healthcare Maternal fetal medicine (MFM) provides routine ultrasound services that’s in tune with your unique needs— for all maternity patients as well as specialized care for high-risk and delivered by people who understand pregnancies, fully integrated with your overall obstetrical care. them. That’s why we’ve created a truly MFM specialists are obstetrician gynecologists (OB/GYNs) who have comprehensive and coordinated system additional training in the assessment and management of high-risk of woman-centered care that covers the pregnancies. This additional care complements the care provided by full spectrum of healthcare needs through obstetricians, family medicine physicians, and midwives, and is focused every phase of a woman’s life. on providing comprehensive assessment and care for the high-risk Our women’s health professionals are mother and fetus in order to achieve the optimal outcome for both. dedicated to providing our full range MFM services include: of services in a manner that simplifies • routine ultrasounds for all pregnancies the healthcare aspect of your busy • care of pregnant women with specific medical problems, such as and multi-faceted life. We’ve even heart disease, hypertension, clotting disorders, thyroid disease, designed the facilities at our Birthing renal disease and substance abuse, and enhanced care programs Center and women’s health facilities for pregnant women with diabetes or a high risk of pre-term labor to be exceptionally warm, welcoming and soothing—helping to provide you • care of pregnant women at risk for complications such as with a care experience that’s both preeclampsia, placental abruption, incompetent cervix, multiple comprehensive and comfortable. gestation, recurrent pregnancy loss and history of stillbirth • care of fetuses with complications related to amniotic fluid Day Kimball Healthcare offers abnormalities, chromosomal abnormalities, congenital anomalies, integrated, comprehensive care fetal anemia, genetic diseases, growth abnormalities such as intra- close to home. To learn more uterine growth restriction, and medication exposure about all of our women’s health • coordination of care for mothers and fetuses whose conditions require that delivery happen at a facility equipped with a neo- services and convenient locations natal intensive care unit. Our close working relationship with major visit daykimball.org/women. medical centers such as UMass Memorial Medical Center, Boston Children’s Hospital, Connecticut Children’s Medical Center and others, provides a seamless transition between our top-notch pre- and post-delivery care and labor and delivery at those facilities. Procedures and services used for monitoring and treating both uncomplicated and high-risk pregnancies include • first and second trimester genetic screening • detailed prenatal ultrasound (2D, 3D and 4D) • fetal testing, including non-stress test and biophysical profile • genetic counseling • invasive fetal testing, including chorionic villus sampling (CVS), amniocentesis and percutaneous umbilical blood sampling, fetal transfusion and other in-utero procedures • non-invasive cell free fetal DNA testing to screen for chromosomal abnormalities • surgery, including cerclage placement • consultative services for all other aspects of prenatal care Billing and Payment Information Maternal Fetal Medicine Please check with your insurance carrier about your specific coverage, Hillside Professional Building copays and deductibles as well as any prior authorization requirements. 346 Pomfret Street Billing for MFM office visits will come from Day Kimball Medical Group Putnam, CT 06260 (DKMG). Billing for ultrasound, lab tests and surgery will come from Day (860) 928-0870 Kimball Hospital as well as our provider partners. Monday - Friday, If you have questions regarding your DKMG bill, please contact the 8:00 a.m. - 5:00 p.m. DKMG business office at (860) 928-9270. For questions related to other bills, please contact our team of financial counselors at Day Kimball Hospital at (860) 963-6337 (at the prompt, enter option 2). For more daykimball.org information visit daykimball.org/billing..
Load more

Recommended publications
  • Chapter 12 Vaginal Breech Delivery
    FOURTH EDITION OF THE ALARM INTERNATIONAL PROGRAM CHAPTER 12 VAGINAL BREECH DELIVERY Learning Objectives By the end of this chapter, the participant will: 1. List the selection criteria for an anticipated vaginal breech delivery. 2. Recall the appropriate steps and techniques for vaginal breech delivery. 3. Summarize the indications for and describe the procedure of external cephalic version (ECV). Definition When the buttocks or feet of the fetus enter the maternal pelvis before the head, the presentation is termed a breech presentation. Incidence Breech presentation affects 3% to 4% of all pregnant women reaching term; the earlier the gestation the higher the percentage of breech fetuses. Types of Breech Presentations Figure 1 - Frank breech Figure 2 - Complete breech Figure 3 - Footling breech In the frank breech, the legs may be extended against the trunk and the feet lying against the face. When the feet are alongside the buttocks in front of the abdomen, this is referred to as a complete breech. In the footling breech, one or both feet or knees may be prolapsed into the maternal vagina. Significance Breech presentation is associated with an increased frequency of perinatal mortality and morbidity due to prematurity, congenital anomalies (which occur in 6% of all breech presentations), and birth trauma and/or asphyxia. Vaginal Breech Delivery Chapter 12 – Page 1 FOURTH EDITION OF THE ALARM INTERNATIONAL PROGRAM External Cephalic Version External cephalic version (ECV) is a procedure in which a fetus is turned in utero by manipulation of the maternal abdomen from a non-cephalic to cephalic presentation. Diagnosis of non-vertex presentation Performing Leopold’s manoeuvres during each third trimester prenatal visit should enable the health care provider to make diagnosis in the majority of cases.
    [Show full text]
  • Computerized Fetal Heart Rate Analysis, Doppler Ultrasound and Biophysical Profile Score in the Prediction of Acid–Base Status of Growth-Restricted Fetuses
    Ultrasound Obstet Gynecol 2007; 30: 750–756 Published online 10 August 2007 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.4101 Computerized fetal heart rate analysis, Doppler ultrasound and biophysical profile score in the prediction of acid–base status of growth-restricted fetuses S. TURAN*†, O. M. TURAN*†, C. BERG‡, D. MOYANO†, A. BHIDE§, S. BOWER†, B. THILAGANATHAN§, U. GEMBRUCH‡, K. NICOLAIDES†, C. HARMAN* and A. A. BASCHAT* *Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland, Baltimore, MD, USA, †Harris Birthright Research Centre for Fetal Medicine, King’s College Hospital and §Fetal Medicine Unit, St George’s Hospital Medical School, London, UK and ‡Department of Obstetrics and Prenatal Medicine, Friedrich-Wilhelm University, Bonn, Germany KEYWORDS: arterial Doppler; biophysical profile scoring; computerized CTG; cord pH; fetal growth restriction; non-stress test; venous Doppler ABSTRACT patients with an equivocal or normal BPS. Abnormal DV Doppler correctly identified false positives among Objective To investigate the performance of non-stress patients with an abnormal BPS. cCTG reduced the rate test (NST), computerized fetal heart rate analysis (cCTG), of an equivocal BPS from 16% to 7.1% when substituted biophysical profile scoring (BPS) and arterial and venous for the traditional NST. Elevated DV Doppler index and Doppler ultrasound investigation in the prediction of umbilical venous pulsations predicted a low pH with 73% acid–base status in fetal growth restriction. sensitivity and 90% specificity (P = 0.008). Methods Growth-restricted fetuses, defined by abdomi- Conclusion In fetal growth restriction with placental nal circumference < 5th percentile and umbilical artery insufficiency, venous Doppler investigation provides the (UA) pulsatility index > 95th percentile, were tested by best prediction of acid–base status.
    [Show full text]
  • Coding for the OB/GYN Practice Coding Principals
    12/4/2013 Coding for the OB/GYN Practice NAMAS 5th Annual Auditing Conference Atlanta, GA December 10, 2013 Peggy Y. Green, CMA(AAMA), CPC, CPMA, CPC‐I Coding Principals • Correct coding implies the selection is – What are we doing? Procedures – Why are we doing it? Diagnosis – Supported by documentation – Consistent with coding guidelines 1 12/4/2013 Coding Principals • Reporting Services – IS there physician work or practice expense? – Can it be supported by an ICD‐9 code? – Is it independent of other procedures/services? – Is there documentation of the service? Billing “Rule” • “Not documented” means “Not done” – “Not documented” “Not billable” • Documentation must support type and level of extent of service reported Code Sets • Key Code sets – HCPCS (includes CPT‐4) – ICD‐9‐CM/ICD‐10‐CM • HCPCS dibdescribes “ht”“what” • ICD‐9 CM describes “why” 2 12/4/2013 Who can bill as a Provider? • Change have been made throughout the CPT manual to clarify who may provide certain services with the addition of the phrase “other qualified healthcare professionals”. • Some codes define that a service is limited to professionals or limited to other entities such as hospitals or home health agencies. Providers • CPT defines a “Physician or other qualified health care professional” as an individual who is qualified by education, training, licensure/regulation (when applicable), and facility privileging (when applicable), who performs a professional services within his/her scope of practice and independently reports that professional service. • This is distinct from clinical staff 3 12/4/2013 Providers • Clinical staff members are people who work under the supervision of a physician or other qualified health care professional and who is allowed by law, regulation, and facility policy to perform or assist in the performance of a specified professional service, but who does not individually report that professional service.
    [Show full text]
  • Therapeutic Amnioinfusion in Oligohydramnios During Pregnancy (Excluding Labor)
    International Journal of Reproduction, Contraception, Obstetrics and Gynecology Qazi M et al. Int J Reprod Contracept Obstet Gynecol. 2017 Oct;6(10):4577-4582 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20174445 Original Research Article Therapeutic amnioinfusion in oligohydramnios during pregnancy (excluding labor) Mahvish Qazi1, Najmus Saqib2*, Abida Ahmed1, Imran Wagay3 1Department of Obstetrics and Gynecology, SKIMS Soura Srinagar Kashmir, India 2Department of Paediatrics and Neonatology, Government Medical College Jammu, Jammu and Kashmir, India 3Department of Radiodiagnosis, Govt. Medical College Srinagar, Jammu and Kashmir, India Received: 05 August 2017 Accepted: 04 September 2017 *Correspondence: Dr. Najmus Saqib, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Oligohydramnios is a serious complication of pregnancy that is associated with a poor perinatal outcome and complicates 1-5% of pregnancies. The purpose of this study was to evaluate the role of antepartum transabdominal amnioinfusion on amniotic fluid volume/latency period in pregnancies with oligohydramnios. Methods: This study was conducted in the Department of Obstetrics and Gynaecology at Sher-i-Kashmir Institute of Medical Sciences Soura Srinagar. In this study, a total of 54 pregnant women with ultrasonographically diagnosed oligohydramnios i.e. AFI < 5 cm and gestational age of >24 weeks were taken for therapeutic amnioinfusion and its effects on amniotic fluid volume were studied.
    [Show full text]
  • Management of Spontaneous Rupture of the Amnion with an Intact Chorion Jenny A
    Jacob et al. Obstet Gynecol cases Rev 2015, 2:5 ISSN: 2377-9004 Obstetrics and Gynaecology Cases - Reviews Case Report: Open Access Management of Spontaneous Rupture of the Amnion with an Intact Chorion Jenny A. Jacob1, Norman A. Ginsberg2, Lee P. Shulman2* and Leeber Cohen2 1Albert-Ludwigs-University School of Medicine, Germany 2Northwestern Feinberg School of Medicine, USA *Corresponding author: Prof. Lee P. Shulman MD, 250 E. Superior Street, Prentice Women’s Hospital, Room 05- 2174, Chicago, IL, USA 60611, Tel: 1.312.730.8694, Email: [email protected] weeks‘gestation with an AFI of 1cm. The patient reported no history Abstract of vaginal amniotic fluid leakage. Speculum examination showed Idiopathic severe preterm oligohydamnios as a result of spontaneous no evidence of vaginal pooling. The fetal kidneys were visualized at rupture of the amnion with an intact chorion is a rare event with a the time of the ultrasound and were considered functioning since scarcity of reports found in the literature. We evaluated the impact the fetal bladder was visualized at the time of ultrasound. Chorionic of serial amnioinfusions on this unusual occurrence. This is a follow- villus sampling (CVS) was performed after the 18-week scan and up of a 37-year-old woman with idiopathic severe oligohydramnios diagnosed at 18 weeks of gestation. We performed five serial showed a normal 46,XX complement. amnioinfusions with the purpose of improving fetal lung maturity The patient was informed of the complications accompanied and to prevent Potter anomalad. At 31 weeks‘gestation the patient with oligohydramnios and was offered pregnancy termination.
    [Show full text]
  • Coding for Multiple Ultrasounds by Emily H
    Coding for multiple ultrasounds By Emily H. Hill, PA In the June 2004 issue [pp 90-97], I discussed the coding guidelines for reporting multiple surgical procedures. There are also instances in which multiple ultrasounds (U/S) are performed, and they can occur on the same day or in the case of obstetrical U/S, during a single pregnancy. Let's look at the case of Desdemona, who has multiple U/S procedures during her pregnancy. Desdemona, a 29-year-old G4P1-0-2-1, presents at 16 weeks to Dr. Cassio for an U/S to assess gestational age and fetal anatomy. Findings revealed fetal biometric parameters consistent with dates. There were no fetal malformations; however, the stomach was not visualized. She was scheduled for a follow-up U/S in 3 weeks. At 19 weeks, Dr. Cassio performed a follow-up U/S. The stomach was visualized and appeared normal. Later that week, Desdemona was given findings from an abnormal triple screen and referred to Dr. Othello, a maternal-fetal medicine specialist who has substantial training in advanced U/S. Dr. Othello performed a detailed fetal anatomic examination, which showed normal fetal anatomy. The patient opted against a genetic amniocentesis. The remainder of Desdemona's pregnancy was uncomplicated and she delivered a healthy 7 lb, 15 oz female at term. Table 1: CPT codes for multiple ultrasounds 76801 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, first trimester (<14 weeks 0 days), transabdominal approach; single or first gestation 76802 each additional gestation
    [Show full text]
  • The Fetal Biophysical Profile All Topics Are Updated As New Evidence
    2017/4/5 The fetal biophysical profile ­ UpToDate Official reprint from UpToDate® www.uptodate.com ©2017 UpToDate® The fetal biophysical profile Author: Frank A Manning, MD Section Editors: Charles J Lockwood, MD, MHCM, Deborah Levine, MD Deputy Editor: Vanessa A Barss, MD, FACOG All topics are updated as new evidence becomes available and our peer review process is complete. Literature review current through: Mar 2017. | This topic last updated: Dec 07, 2016. INTRODUCTION — The fetal biophysical profile (BPP) is a noninvasive, easily learned and performed procedure for evaluating the fetus for signs of compromise. Ultrasound is used to assess four discrete biophysical parameters: fetal movement, fetal tone, fetal breathing, and amniotic fluid volume. A separate nonstress test of the fetal heart rate can also be performed. Each of the four ultrasound parameters and the nonstress test are given a score of 0 or 2 points (no 1 point), depending upon whether specific criteria are met (table 1). A total score ≥8 implies absence of significant central nervous system hypoxemia/acidemia at the time of testing. A score ≤4 can be a sign of fetal compromise. Ideally, identification of a compromised fetus will enable the provider to perform interventions that prevent adverse fetal sequelae. This topic will review issues related to the BPP. An overview of antenatal fetal surveillance and information on the nonstress test and the contraction stress test are available separately. (See "Overview of antepartum fetal surveillance" and "Nonstress test and contraction stress test".) INDICATIONS — The American College of Obstetricians and Gynecologists recommends antepartum fetal surveillance with tests such as the BPP for pregnancies at increased risk of antepartum fetal demise [1].
    [Show full text]
  • Biophysical Profile and Modified Biophysical Profile in Predicting the Fetal Outcome
    International Journal of Reproduction, Contraception, Obstetrics and Gynecology Vanamala VG et al. Int J Reprod Contracept Obstet Gynecol. 2018 Sep;7(9):3516-3519 www.ijrcog.org pISSN 2320-1770 | eISSN 2320-1789 DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20183374 Original Research Article Biophysical profile and modified biophysical profile in predicting the fetal outcome V. G. Vanamala1, Aruna Rachel1*, Sushil Pakyanadhan2, Sudeep Abraham P.3 1Department of Obstetrics and Gynecology, VRK Womens Medical College and Hospital and Research Centre, Hyderabad, Telangana, India 2Department of Pathology, 3Department of Surgery, Shadan Institute of Medical Sciences, Hyderabad, Telangana, India Received: 18 July 2018 Accepted: 23 July 2018 *Correspondence: Dr. Aruna Rachel, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Baby’s well-being in utero is often done by using a cardiotocograph (CTG) machine, which assesses the baby’s heart beat pattern as well as the mother’s uterine contractions. However, lowered fetal movements sometimes may be fatal for the baby. Thus, the biophysical and the modified biophysical profile have been introduced. Methods: 242 patients with over 34 weeks of gestation and with one or more risk factors were included in the study. After taking the demographic details, the patients were subjected to detailed physical and clinical evaluation. Modified BPP was done on all the patients.
    [Show full text]
  • Biophysical Profile
    Texas Tech University Health Sciences Center El Paso Department of Obstetrics and Gynecology Protocol #3 The Biophysical Profile Background The biophysical profile (BPP) is based on the concept that fetal breathing, movement and tone are mediated by neurological pathways and therefore reflect the fetal CNS status at the time of the examination. Amniotic fluid level is a measure of chronic asphyxia or placental function. The addition of the evaluation of the fetal heart rate variability (NST) to the BPP increases the sensitivity for acute status changes. The BPP represents the in-utero APGAR score and has been shown to correlate well with the acid-base status of babies delivered by cesarean section prior to the onset of labor. The earliest signs of fetal acidosis are a nonreactive NST and loss of fetal breathing. A significant inverse correlation between the BPP score and perinatal morbidity and mortality has been documented. BPP ≥ 8/10 accurately predicts normal tissue oxygenation with false negative rate <1% BPP ≤ 6/10 is a relatively accurate predictor of acidemia BPP = 0/10 has near 100% sensitivity for acidemia Administration of antenatal corticosteroids can decrease the BPP score. This effect usually resolves within 48 hours. A. Indications 1. Patients with a nonreactive NST 2. Any patient where further confirmation of fetal well-being is desired 3. The BPP should not be performed before 24 weeks B. Technique 1. The patient is placed into a supine position. 2. The fetus is observed, by ultrasound, for up to 30 minutes. During the 30 minutes, the components of the BPP are sought.
    [Show full text]
  • Integrated Testing and Management in Fetal Growth Restriction Sifa Turan, MD, RDMS, Jena Miller, MD, and Ahmet A
    Integrated Testing and Management in Fetal Growth Restriction Sifa Turan, MD, RDMS, Jena Miller, MD, and Ahmet A. Baschat, MD Growth-restricted fetuses are at higher risk for poor perinatal and long-term outcome than those who are appropriately grown. Multiple antenatal testing modalities can help docu- ment the sequence of fetal deterioration. The full extent of this compromise is best identified by a combination of fetal biometry, biophysical profile scoring, and arterial and venous Doppler. In the preterm growth-restricted fetus, timing of delivery is critically determined by the balance of fetal versus neonatal risks. In the near-term fetus, accurate diagnosis continues to be a challenge as unrecognized growth restriction contributes to a significant proportion of unexplained stillbirths. In this review, we present an integrated diagnostic and surveillance approach that accounts for these factors. Semin Perinatol 32:194-200 © 2008 Elsevier Inc. All rights reserved. KEYWORDS fetal growth restriction, non stress testing, computerized cardiotocography, bio- physical profile scoring, Doppler ultrasound, integrated testing valuation of fetal growth is common obstetric practice. havioral or cardiovascular responses to hypoxemia, but when EFetal growth restriction (FGR) affects 15% of pregnan- used in isolation may have limitations in the management of cies and is associated with significant morbidity and mortal- FGR. Integration of antenatal assessment modalities concur- ity in perinatal and adult life.1 Clinical suspicion of FGR rently evaluates physical, behavioral, and cardiovascular requires further investigation as growth delay may be the manifestations of FGR. This approach can bypass the limita- physical manifestation of many possible conditions. When tions of individual tests and therefore provide the most com- FGR is established early in pregnancy, the diagnosis is readily prehensive insight into the fetal condition to guide manage- made.
    [Show full text]
  • Preliminary Experience of Amnioinfusion
    The Seoul Jollrnal oJ',2.ledicine vol. 34, No. 3 195-205,September 199.3 Preliminary Experience of Amnioinfusion Woo Jin Kim, Bo Hyun Yoon, Sook Hyun Ki, Me Lee Lee, Jong Kwan Jeon, Hee Chul Syn and Syng Wook Kim Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul 110-744, Korea = A bst ract = Oligohydramnios is considered as one of the major obstetrical dilem- mas for the multiple serious complications associated with the condition. The condition hampers an appropriate ultrasonographic evaluation of the fetal anato- my and frequently causes variable fetal heart rate decelerations by compressing the fetal cord, often to incur irreversible damage to the fetus. Based on precedent reports regarding the effect of amnioinfusion in managing oligohydramnios-com- plicated pregnancies, we report here our experience of amnioinfusion in 8 cases complicated by oligohydramnios which we have experienced from November of 1990 to May of 1993 at Seoul National University Hospital(SNUH). The proce- dure was applied largely for three purposes, viz., diagnostic(3cases), therapeutic (4cases), and prophylactic(1case) with favorable results. We concluded that amnioinfusion can be of important use in the detection of fetal anomalies, relief of abnormal fetal heart rate pattern, and prevention of intrapartum fetal compli- cations. Key Wo rd s : Oligohydramnios, Fetal heart rate decelerations, Amnioinfision right time. Complications associated with oligo- INTRODUCTION hydramnios are multiple, but two are well known. One
    [Show full text]
  • 00I-Iv Sieog Linee Guida 2010-2.Pmd
    I LINEE GUIDA SIEOG Società Italiana di Ecografia Ostetrico Ginecologica Edizione 2010 SIEOG II SIEOG Società Italiana di Ecografia Ostetrico Ginecologica e Metodologie Biofisiche Segreteria permanente e tesoreria: Via dei Soldati, 25 - 00186 ROMA - Tel. 06.6875119 - Fax 06.6868142 [email protected] - www.sieog.it - C/C postale N. 20857009 CONSIGLIO DIRETTIVO 2008-2010 PRESIDENTE Paolo Volpe (Bari) PAST-PRESIDENT Tullia Todros (Torino) VICEPRESIDENTI Clara Sacchini (Parma) Antonia Testa (Roma) CONSIGLIERI Carolina Axiana (Cagliari) Elisabetta Coccia (Firenze) Lucia Lo Presti (Catania) Simona Melazzini (Udine) Giuliana Simonazzi (Bologna) TESORIERE Cinzia Taramanni (Roma) SEGRETARIO Valentina De Robertis (Bari) Copyright © 2010 ISBN: 88-6135-124-7 978-88-6135-124-0 Via Gennari 81, 44042 Cento (FE) Tel. 051.904181/903368 Fax 051.903368 www.editeam.it [email protected] Progetto Grafico: EDITEAM Gruppo Editoriale Tutti i diritti sono riservati. Nessuna parte di questa pubblicazione può essere riprodotta, trasmessa o memorizzata in qualsiasi forma e con qualsiasi mezzo senza il permesso scritto dell’Editore. Finito di stampare nel mese di Ottobre 2010. LETTERA AI SOCI III Cari Soci, come da impegno preso per iscritto negli anni precedenti che cadenzava l’aggiornamento delle Linee Guida SIEOG ad un intervallo di 3 anni, allo scadere del mandato di questo Consiglio di Presidenza (CDP) presentiamo la revisione delle LG SIEOG. Sono state realizzate in sintonia con il lavoro dei colleghi dei CDP che ci hanno preceduto e che ha portato alla pubblicazione delle precedenti LG nel 1996, 2002 e 2006. Sono espressione della continua evoluzione scientifica e tecnologica nel nostro settore nonché del ruolo importante, che dal punto di vista clinico, la metodica ecografica ha raggiunto nella nostra disciplina.
    [Show full text]